These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 11721177)

  • 1. STn and prognosis in breast cancer.
    Leivonen M; Nordling S; Lundin J; von Boguslawski K; Haglund C
    Oncology; 2001; 61(4):299-305. PubMed ID: 11721177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of sialyl-Tn antigen is correlated with survival time of patients with gastric carcinomas.
    Ma XC; Terata N; Kodama M; Jancic S; Hosokawa Y; Hattori T
    Eur J Cancer; 1993; 29A(13):1820-3. PubMed ID: 8260233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sialyl-Tn antigen expression occurs early during human mammary carcinogenesis and is associated with high nuclear grade and aneuploidy.
    Cho SH; Sahin A; Hortobagyi GN; Hittelman WN; Dhingra K
    Cancer Res; 1994 Dec; 54(24):6302-5. PubMed ID: 7987817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sialyl-Tn antigen as a useful predictor of poor prognosis in patients with advanced stomach cancer.
    Terashima S; Takano Y; Ohori T; Kanno T; Kimura T; Motoki R; Kawaguchi T
    Surg Today; 1998; 28(7):682-6. PubMed ID: 9697259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced prediction of breast cancer prognosis by evaluating expression of p53 and prostate-specific antigen in combination.
    Yu H; Levesque MA; Clark GM; Diamandis EP
    Br J Cancer; 1999 Oct; 81(3):490-5. PubMed ID: 10507775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sialyl Tn is a frequently expressed antigen in colorectal cancer: No correlation with patient prognosis.
    Lundin M; Nordling S; Roberts PJ; Lundin J; Carpelan-Holmström M; von Boguslawsky K; Haglund C
    Oncology; 1999 Jul; 57(1):70-6. PubMed ID: 10394128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA ploidy is an independent predictor of survival in breast invasive ductal carcinoma: a long-term multivariate analysis of 393 patients.
    Pinto AE; Pereira T; Santos M; Branco M; Dias A; Silva GL; Ferreira MC; André S
    Ann Surg Oncol; 2013 May; 20(5):1530-7. PubMed ID: 23250736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sialosyl Tn antigen expression is associated with the prognosis of patients with advanced gastric cancer.
    Yamada T; Watanabe A; Yamada Y; Shino Y; Tanase M; Yamashita J; Miwa T; Nakano H
    Cancer; 1995 Nov; 76(9):1529-36. PubMed ID: 8635053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of cytosolic p53 protein in breast cancer.
    Montero S; Guzmán C; Vargas C; Ballestín C; Cortés-Funes H; Colomer R
    Tumour Biol; 2001; 22(5):337-44. PubMed ID: 11553865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sialyl Tn antigen is an independent predictor of outcome in patients with gastric cancer.
    Victorzon M; Nordling S; Nilsson O; Roberts PJ; Haglund C
    Int J Cancer; 1996 Jan; 65(3):295-300. PubMed ID: 8575847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation between sialyl Tn antigen and lymphatic metastasis in patients with Borrmann type IV gastric carcinoma.
    Kakeji Y; Maehara Y; Morita M; Matsukuma A; Furusawa M; Takahashi I; Kusumoto T; Ohno S; Sugimachi K
    Br J Cancer; 1995 Jan; 71(1):191-5. PubMed ID: 7819038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Redefining prognostic factors for breast cancer: YB-1 is a stronger predictor of relapse and disease-specific survival than estrogen receptor or HER-2 across all tumor subtypes.
    Habibi G; Leung S; Law JH; Gelmon K; Masoudi H; Turbin D; Pollak M; Nielsen TO; Huntsman D; Dunn SE
    Breast Cancer Res; 2008; 10(5):R86. PubMed ID: 18925950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A risk score for predicting outcome in patients with gastric cancer, based on stage, sialyl-Tn immunoreactivity and ploidy--a multivariate analysis.
    Victorzon M; Lundin J; Haglund C; Nordling S; Roberts PJ
    Int J Cancer; 1996 Jul; 67(2):190-3. PubMed ID: 8760586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Independent prognostic value of hormone receptor expression and S-phase fraction in advanced breast cancer.
    Pinto AE; Mendonça E; André S; Nóbrega SD; Soares J
    Anal Quant Cytol Histol; 2002 Dec; 24(6):345-54. PubMed ID: 12508694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of sialyl-Tn predicts the effect of adjuvant chemotherapy in node-positive breast cancer.
    Miles DW; Happerfield LC; Smith P; Gillibrand R; Bobrow LG; Gregory WM; Rubens RD
    Br J Cancer; 1994 Dec; 70(6):1272-5. PubMed ID: 7981088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutant p53 expression and DNA analysis in human breast cancer comparison with conventional clinicopathological parameters.
    Rosanelli GP; Steindorfer P; Wirnsberger GH; Klimpfinger M; Ratschek M; Puerstner P; Auner H; Berhold A
    Anticancer Res; 1995; 15(2):581-6. PubMed ID: 7763041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of prostate-specific antigen for women with breast cancer: a large United States cohort study.
    Yu H; Levesque MA; Clark GM; Diamandis EP
    Clin Cancer Res; 1998 Jun; 4(6):1489-97. PubMed ID: 9626467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sialyl Tn antigen expression is associated with the prognosis of patients with advanced colorectal cancer.
    Imada T; Rino Y; Hatori S; Takahashi M; Amano T; Kondo J; Suda T
    Hepatogastroenterology; 1999; 46(25):208-14. PubMed ID: 10228794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum Sialyl-Tn (STN) as a Tumor Marker in Patients with Endometrial Cancer.
    Hashiguchi Y; Kasai M; Fukuda T; Ichimura T; Yasui T; Sumi T
    Pathol Oncol Res; 2016 Jul; 22(3):501-4. PubMed ID: 26678075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of carbohydrate antigens in advanced-stage ovarian carcinomas and their metastases-A clinicopathologic study.
    Davidson B; Gotlieb WH; Ben-Baruch G; Kopolovic J; Goldberg I; Nesland JM; Berner A; Bjåmer A; Bryne M
    Gynecol Oncol; 2000 Apr; 77(1):35-43. PubMed ID: 10739688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.